Beauty

Shiseido to sell Aupres maker SLC to IDG-led consortium

Binding deal transfers control of Shiseido Liyuan Cosmetics, including its Beijing factory, as the group refocuses on priority brands.

Evelina SandbergNovember 19, 20265 min read0 views

Unbranded skincare jars and bottles sit on a laboratory workbench, with production equipment blurred behind a translucent geometric partition.

Shiseido has signed a binding agreement to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to an investor group led by Hong Kong-based private equity firm IDG Capital. SLC manufactures and sells the Aupres brand in China. The Japanese cosmetics group did not disclose financial terms. The deal is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals, including in China.

The sale is part of Shiseido’s 2030 Medium-Term Strategy, under which it aims to improve profitability and capital efficiency. Shiseido said it intends to concentrate management resources on areas where it has the greatest competitive advantage, focus on priority brands and pursue higher-growth opportunities. The subsidiary being sold requires continued investment in product innovation and digital capabilities, according to the company.

Shiseido described China as a strategically important market and an attractive, dynamic one. It said the competitive landscape there continues to change as e-commerce expands rapidly, consumer behavior shifts and a wider range of market participants emerges.

SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group, which is owned by the Beijing Municipal Government. The company has sold Aupres, described in the announcement as a C-beauty brand, since 1994. With the joint venture agreement due to expire in December 2026, the partners agreed not to renew it. On September 1, 2026, Shiseido acquired Beijing Liyuan’s 35% stake, giving it full ownership before the sale.

Under the transaction, funds managed by IDG Capital will hold 95% of SLC’s equity through two special purpose vehicles. A limited partnership enterprise established mainly by SLC’s new management team will hold the remaining 5%. The deal includes SLC’s Beijing factory and production equipment. Shiseido said it believes independent operation under IDG can support SLC’s sustainable growth and brand value.

To support the handover, Shiseido will license the intellectual property rights IDG needs to run the business. For a specified period after the transfer, Shiseido will also provide support for new product development, technical assistance to maintain stable supply of existing products, and continued supply of raw materials and selected products. The company said these arrangements are intended to preserve SLC’s innovation capabilities, product quality and business continuity.

The divestment was announced days after Shiseido reported a 124.3% increase in core operating profit for the third quarter of 2026, to ¥67.5 billion (US$422.13 million). Shiseido attributed the recovery to restructuring, cost cuts and improved margins rather than strong product demand; like-for-like sales rose 0.7%. It raised its full-year core operating profit forecast from ¥59 billion (US$433 million) to ¥87 billion (US$546 million).